The US went crazy for Seabiscuit when he won his famous 1938 match race against War Admiral. Now researchers are investigating the thoroughbred's DNA to see what made him such an unlikely success.
New genetic knowledge about cane toads could give us the knowledge we need to throw some more roadblocks in front of this persistent invader as it marches across Australia.
Figuring out what causes diseases like autism, schizophrenia and depression is tricky. Now Stanford University researchers are turning blood into brain cells to study these diseases in a dish.
When you send off a cheek swab to one of the private genome companies, you may sacrifice not just your own privacy but that of your family and your ancestors.
"Precision medicine" is allowing us to analyse a person's genetic makeup and target treatments based on their specific needs.
It's exciting to think we're on the brink of a genomic revolution in health care. But just because new technology becomes available, it doesn't mean it should automatically be publicly funded.
Politics Podcast: Bill Ferris on Australia’s innovation mission.
CC BY46.8 MB (download)
Innovation and Science Australia chair Bill Ferris launched a report this week setting out a plan that seeks to put Australia into the top tier of innovation nations by 2030.
Treating video like a mutating gene could improve surveillance software.
Colin Smith became the first person to donate his genomic data to the Personal Genome Project UK under 'open consent' – waiving rights to anonymity.
Some animals seem to have missing genes – but the reality is a lot more intriguing.
Once online, our healthcare data could be used for research long after we're gone.
A diagnosis of glioblastoma did not keep John McCain from the Capitol to cast a crucial vote that could end Obamacare. His actions are a reminder that stats are one thing but human beings, another.
A freedom of information request reveals that Google wants its AI company DeepMind to get involved in the 100,000 Genomes Project.
A test of all your genes for disease risk is not yet the precision diagnostic and treatment tool we hope it will one day be.
The advent of genetic technologies has been reducing the time and cost attached to diagnosing rare genetic diseases.
A new code of conduct for researchers has been developed by the San peoples of southern Africa.
Although genomics research has the potential to revolutionize medicine, it has limitations. It may not do much to prevent many of the leading causes of death.
Not only are tumors are different from one another, but there can even be genetic differences within a single tumor.
New regulations for research with human blood and tissue try to balance scientific progress with patient privacy.
Researchers are developing biological tools that can boost crop yields to feed a growing world population without harming human health or the environment.